Loading...
Please wait, while we are loading the content...
Similar Documents
Glycolipid ligands of invariant natural killer T cells as vaccine adjuvants
| Content Provider | Scilit |
|---|---|
| Author | Kim, Sungjune Lalani, Saif Parekh, Vrajesh V. Wu, Lan Kaer, Luc Van |
| Copyright Year | 2008 |
| Description | Invariant natural killer T (iNKT) cells are a unique subset of T lymphocytes that recognize glycolipid antigens in the context of the antigen-presenting molecule CD1d. Upon glycolipid antigen stimulation, iNKT cells rapidly produce copious amounts of immunomodulatory cytokines, leading to potent activation of a variety of innate and adaptive immune cells. These immune-potentiating properties of iNKT cells hold great promise for the development of vaccine adjuvants. This review aims to summarize the immunomodulatory activities of iNKT cell ligands and to discuss prospects for developing iNKT cell-based vaccine adjuvants. |
| Related Links | http://europepmc.org/articles/pmc2680388?pdf=render https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2680388/pdf |
| Ending Page | 1532 |
| Page Count | 14 |
| Starting Page | 1519 |
| ISSN | 14760584 |
| e-ISSN | 17448395 |
| DOI | 10.1586/14760584.7.10.1519 |
| Journal | Expert Review of Vaccines |
| Issue Number | 10 |
| Volume Number | 7 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2008-12-01 |
| Access Restriction | Open |
| Subject Keyword | Α-galactosylceramide Adjuvant Antigen Presentation Glycolipid Innate Immunity Invariant Natural Killer T Cell |
| Content Type | Text |
| Resource Type | Article |
| Subject | Drug Discovery Pharmacology Immunology Molecular Medicine |